GlucoTrack, Inc. (GCTK)
2.93
-0.05
(-1.68%)
USD |
NASDAQ |
Sep 08, 16:00
2.97
+0.04
(+1.37%)
Pre-Market: 09:15
GlucoTrack Total Assets (Quarterly) : 1.495M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.495M |
| March 31, 2026 | 4.356M |
| December 31, 2025 | 7.838M |
| September 30, 2025 | 8.29M |
| June 30, 2025 | 10.21M |
| March 31, 2025 | 9.612M |
| December 31, 2024 | 5.932M |
| September 30, 2024 | 0.826M |
| June 30, 2024 | 0.608M |
| March 31, 2024 | 2.106M |
| December 31, 2023 | 4.905M |
| September 30, 2023 | 7.195M |
| June 30, 2023 | 8.982M |
| March 31, 2023 | 1.246M |
| December 31, 2022 | 2.434M |
| September 30, 2022 | 3.493M |
| June 30, 2022 | 4.308M |
| March 31, 2022 | 5.348M |
| December 31, 2021 | 6.265M |
| September 30, 2021 | 7.608M |
| June 30, 2021 | 8.597M |
| March 31, 2021 | 9.628M |
| December 31, 2020 | 10.61M |
| September 30, 2020 | 11.43M |
| June 30, 2020 | 12.15M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.27M |
| December 31, 2019 | 1.096M |
| September 30, 2019 | 1.974M |
| June 30, 2019 | 3.055M |
| March 31, 2019 | 0.8391M |
| December 31, 2018 | 0.6882M |
| September 30, 2018 | 2.458M |
| June 30, 2018 | 1.502M |
| March 31, 2018 | 1.905M |
| December 31, 2017 | 1.669M |
| September 30, 2017 | 2.649M |
| June 30, 2017 | 3.388M |
| March 31, 2017 | 3.796M |
| December 31, 2016 | 2.461M |
| September 30, 2016 | 2.029M |
| June 30, 2016 | 2.742M |
| March 31, 2016 | 1.537M |
| December 31, 2015 | 2.133M |
| September 30, 2015 | 3.019M |
| June 30, 2015 | 4.151M |
| March 31, 2015 | 5.182M |
| December 31, 2014 | 6.348M |
| September 30, 2014 | 4.951M |
| June 30, 2014 | 1.020M |
| March 31, 2014 | 1.982M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nuwellis, Inc. | 9.126M |
| Abbott Laboratories | 109.22B |
| DexCom, Inc. | 6.455B |
| Insulet Corp. | 3.165B |
| AngioDynamics, Inc. | 267.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.236M |
| Shareholders Equity (Quarterly) | -1.741M |
| Debt to Equity Ratio | -1.125 |
| Current Ratio | 0.4622 |
| Net Debt Paydown Yield | -17.00% |